Robert Fried - Chromadex Corp Independent Director
CDXCDelisted Stock | USD 7.74 0.13 1.65% |
Director
Mr. Robert N. Fried serves as President, Chief Executive Officer, Chief Operating Officer, Chief Strategy Officer, Director of the Company, has served as a director of the Company since July 2015 and has served as a member of the Nominating and Corporationrationrate Governance Committee from July 2015 to March 2017. Mr. Fried was appointed President and Chief Strategy Officer of the Company in March 2017 and also became its Chief Operating Officer in January 2018. In April 2018, the Board of Directors approved a future transition of Mr. Fried whereby Mr. Fried will transition from his role as President and Chief Operating Officer to serve as Chief Executive Officer of the Company, each effective as of the conclusion of the Annual Meeting. Mr. Fried served as Chairman of the Board of Directors of IDI, Inc., an information solutions provider focused on the data fusion market and formerly a Chinese advertising company prior to its merger with the parent company of Interactive Data, LLC, from 2011 until June 2015. From 2007 through 2009, he was the president, Chief Executive Officer and a director of Ideation Acquisition Corporationrationration, a special purpose acquisition company. Mr. Fried is the founder and Chief Executive Officer of Feeln, a subscription streaming video service, which was acquired by Hallmark Cards Inc. in 2012. Since then, Mr. Fried manages digital businesses for Hallmark including Feeln, Hallmark ecards, and Hallmark Print on Demand. Mr. Fried is also an Academy Award winning motion picture producer whose credits include Rudy, Collateral, Boondock Saints, So I Married an Axe Murderer, Godzilla, and numerous others. From December 1994 until June 1996, he was President and Chief Executive Officer of Savoy Pictures, a unit of Savoy Pictures Entertainment, Inc., which was sold in 1996 to Silver King Communications, which is now a part of InterActive Corporationration since 2018.
Age | 65 |
Tenure | 7 years |
Phone | 310 388 6706 |
Web | https://www.chromadex.com |
Robert Fried Latest Insider Activity
Tracking and analyzing the buying and selling activities of Robert Fried against Chromadex Corp stock is an integral part of due diligence when investing in Chromadex Corp. Robert Fried insider activity provides valuable insight into whether Chromadex Corp is net buyers or sellers over its current business cycle. Note, Chromadex Corp insiders must abide by specific rules, including filing SEC forms every time they buy or sell Chromadex Corp'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Robert Fried over a year ago Acquisition by Robert Fried of 9568 shares of Chromadex Corp at 1.52 subject to Rule 16b-3 |
Chromadex Corp Management Efficiency
The company has return on total asset (ROA) of 0.0784 % which means that it generated a profit of $0.0784 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.2294 %, meaning that it created $0.2294 on every $100 dollars invested by stockholders. Chromadex Corp's management efficiency ratios could be used to measure how well Chromadex Corp manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Found 3 records | DIRECTOR Age | ||
Jiyoung Hwang | Exicure | 48 | |
John Fowler | Kezar Life Sciences | 53 | |
Raquel MS | HCW Biologics | N/A |
Management Performance
Return On Equity | 0.23 | ||||
Return On Asset | 0.0784 |
Chromadex Corp Leadership Team
Elected by the shareholders, the Chromadex Corp's board of directors comprises two types of representatives: Chromadex Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Chromadex. The board's role is to monitor Chromadex Corp's management team and ensure that shareholders' interests are well served. Chromadex Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Chromadex Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
Kendall Knysch, Head Partnerships | ||
Heather Blarcom, Senior Secretary | ||
Brianna Gerber, Senior Director of FP&A, IR Contact Officer | ||
Andrew Shao, Senior Affairs | ||
Frank Jaksch, Co-Founder, CEO and President and Director | ||
Chu Yan, Managing Pacific | ||
Ozan CFA, CFO Officer | ||
Robert Fried, Independent Director | ||
James Lee, Principal CFO | ||
David Kroes, Senior Matters | ||
Jason Campbell, Senior Development | ||
Michiko Kelley, Chief Officer | ||
Alex Worsham, Vice Communications | ||
Tom Shumaker, Managing Advisors | ||
Fadi Karam, Chief Officer | ||
Carlos Lopez, Senior Counsel |
Chromadex Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Chromadex Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.23 | ||||
Return On Asset | 0.0784 | ||||
Profit Margin | 0.09 % | ||||
Operating Margin | 0.24 % | ||||
Current Valuation | 567.71 M | ||||
Shares Outstanding | 77.75 M | ||||
Shares Owned By Insiders | 34.79 % | ||||
Shares Owned By Institutions | 30.00 % | ||||
Number Of Shares Shorted | 2.19 M | ||||
Price To Earning | (19.51) X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chromadex Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Consideration for investing in Chromadex Stock
If you are still planning to invest in Chromadex Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Chromadex Corp's history and understand the potential risks before investing.
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |